IBDEI0DF ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6412,1,5,0)
 ;;=5^244.9
 ;;^UTILITY(U,$J,358.3,6412,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,6413,0)
 ;;=244.1^^44^515^16
 ;;^UTILITY(U,$J,358.3,6413,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6413,1,4,0)
 ;;=4^POST I-131
 ;;^UTILITY(U,$J,358.3,6413,1,5,0)
 ;;=5^244.1
 ;;^UTILITY(U,$J,358.3,6413,2)
 ;;=^267816
 ;;^UTILITY(U,$J,358.3,6414,0)
 ;;=244.0^^44^515^17
 ;;^UTILITY(U,$J,358.3,6414,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6414,1,4,0)
 ;;=4^POSTSURGICAL HYPOTHYROID
 ;;^UTILITY(U,$J,358.3,6414,1,5,0)
 ;;=5^244.0
 ;;^UTILITY(U,$J,358.3,6414,2)
 ;;=^267814
 ;;^UTILITY(U,$J,358.3,6415,0)
 ;;=246.0^^44^515^10
 ;;^UTILITY(U,$J,358.3,6415,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6415,1,4,0)
 ;;=4^HYPERTHYROCALCITONIN
 ;;^UTILITY(U,$J,358.3,6415,1,5,0)
 ;;=5^246.0
 ;;^UTILITY(U,$J,358.3,6415,2)
 ;;=^267827
 ;;^UTILITY(U,$J,358.3,6416,0)
 ;;=241.0^^44^515^20
 ;;^UTILITY(U,$J,358.3,6416,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6416,1,4,0)
 ;;=4^THYROID NODULE
 ;;^UTILITY(U,$J,358.3,6416,1,5,0)
 ;;=5^241.0
 ;;^UTILITY(U,$J,358.3,6416,2)
 ;;=^83865
 ;;^UTILITY(U,$J,358.3,6417,0)
 ;;=242.10^^44^515^21
 ;;^UTILITY(U,$J,358.3,6417,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6417,1,4,0)
 ;;=4^THYROID NODULE,HOT
 ;;^UTILITY(U,$J,358.3,6417,1,5,0)
 ;;=5^242.10
 ;;^UTILITY(U,$J,358.3,6417,2)
 ;;=^267797
 ;;^UTILITY(U,$J,358.3,6418,0)
 ;;=245.0^^44^515^1
 ;;^UTILITY(U,$J,358.3,6418,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6418,1,4,0)
 ;;=4^ACUTE THYROIDITIS
 ;;^UTILITY(U,$J,358.3,6418,1,5,0)
 ;;=5^245.0
 ;;^UTILITY(U,$J,358.3,6418,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,6419,0)
 ;;=245.2^^44^515^3
 ;;^UTILITY(U,$J,358.3,6419,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6419,1,4,0)
 ;;=4^CHR LYMPHOCYT THYROIDIT
 ;;^UTILITY(U,$J,358.3,6419,1,5,0)
 ;;=5^245.2
 ;;^UTILITY(U,$J,358.3,6419,2)
 ;;=^119344
 ;;^UTILITY(U,$J,358.3,6420,0)
 ;;=245.1^^44^515^18
 ;;^UTILITY(U,$J,358.3,6420,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6420,1,4,0)
 ;;=4^SUBACUTE THYROIDITIS
 ;;^UTILITY(U,$J,358.3,6420,1,5,0)
 ;;=5^245.1
 ;;^UTILITY(U,$J,358.3,6420,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,6421,0)
 ;;=252.1^^44^515^11
 ;;^UTILITY(U,$J,358.3,6421,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6421,1,4,0)
 ;;=4^HYPOPARATHYROIDISM
 ;;^UTILITY(U,$J,358.3,6421,1,5,0)
 ;;=5^252.1
 ;;^UTILITY(U,$J,358.3,6421,2)
 ;;=^60635
 ;;^UTILITY(U,$J,358.3,6422,0)
 ;;=252.01^^44^515^8
 ;;^UTILITY(U,$J,358.3,6422,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6422,1,4,0)
 ;;=4^HYPERPARATHYROID,PRIMARY
 ;;^UTILITY(U,$J,358.3,6422,1,5,0)
 ;;=5^252.01
 ;;^UTILITY(U,$J,358.3,6422,2)
 ;;=^331439
 ;;^UTILITY(U,$J,358.3,6423,0)
 ;;=252.02^^44^515^13
 ;;^UTILITY(U,$J,358.3,6423,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6423,1,4,0)
 ;;=4^HYPRPRTHYRD NONRENAL,SEC
 ;;^UTILITY(U,$J,358.3,6423,1,5,0)
 ;;=5^252.02
 ;;^UTILITY(U,$J,358.3,6423,2)
 ;;=^331440
 ;;^UTILITY(U,$J,358.3,6424,0)
 ;;=226.^^44^515^2
 ;;^UTILITY(U,$J,358.3,6424,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6424,1,4,0)
 ;;=4^BENIGN NEOPLASM THYROID
 ;;^UTILITY(U,$J,358.3,6424,1,5,0)
 ;;=5^226.
 ;;^UTILITY(U,$J,358.3,6424,2)
 ;;=^267686
 ;;^UTILITY(U,$J,358.3,6425,0)
 ;;=240.0^^44^515^6
 ;;^UTILITY(U,$J,358.3,6425,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6425,1,4,0)
 ;;=4^GOITER,SIMPLE
 ;;^UTILITY(U,$J,358.3,6425,1,5,0)
 ;;=5^240.0
 ;;^UTILITY(U,$J,358.3,6425,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,6426,0)
 ;;=242.31^^44^515^5
 ;;^UTILITY(U,$J,358.3,6426,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6426,1,4,0)
 ;;=4^GOITER W/ CRISIS,TOX NOD
 ;;^UTILITY(U,$J,358.3,6426,1,5,0)
 ;;=5^242.31
